FDA Approves Cyltezo as Interchangeable Biosimilar with Humira October 21, 2021 Auto Bot News 0 Boehringer Ingelheim’s Cyltezo (adalimumab-adbm) is the first FDA approved interchangeable biosimilar for Humira.
